Seeking Alpha

Oppenheimer says Mindray Medical (MR) should be bought into its Q4 results due out on February...

Oppenheimer says Mindray Medical (MR) should be bought into its Q4 results due out on February 27. The firm believes guidance is too conservative, and the firm expects the company's margins to expand this year.
From other sites
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs